Clinical Trial Update: Acamprosate and Methazolamide for Essential Tremor [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating acamprosate and methazolamide for essential tremor was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Tremor

Drugs mentioned

• Methazolamide (Methazolamide)
• acamprosate (acamprosate)

Snippet

Sponsor: Henry Ford Health System | Conditions: Essential Tremor | Phase 2 | Status: WITHDRAWN